Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
Nadine Bossard
(1, 2)
,
Michel Velten
(3)
,
Laurent Remontet
(1, 2)
,
Aurélien Belot
(1, 2, 4)
,
Nabil Maarouf
(3)
,
Anne Marie Bouvier
(3)
,
Anne-Valérie Guizard
(3)
,
Brigitte Tretarre
(3)
,
Guy Launoy
(3)
,
Marc Colonna
(3)
,
Arlette Danzon
(3, 5)
,
Florence Molinie
(3)
,
Xavier X. Troussard
(3)
,
Nicole Bourdon-Raverdy
(3)
,
P. M. Carli
(3)
,
A. Jaffré
(3)
,
C. Bessaguet
(3)
,
E. Sauleau
(3)
,
Claire Schvartz
(3)
,
Patrick Arveux
(3)
,
Marc Maynadié
(3)
,
Pascale Grosclaude
(3)
,
Jacques Estève
(1, 2)
,
Jean Faivre
(3)
Nadine Bossard
- Function : Author
- PersonId : 169595
- IdHAL : nadine-bossard
- IdRef : 077465946
Laurent Remontet
- Function : Author
- PersonId : 734937
- IdHAL : laurent-remontet
- ORCID : 0000-0003-3393-4216
- IdRef : 240833201
Abstract
We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.